Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921188 | 0.86 | — | — | |
| SCHEMBL750102 | 0.79 | — | — | |
| SCHEMBL5482843 | 0.75 | DPP4 (0.40) | DPP4DPP7 | |
| SCHEMBL14270060 | 0.75 | DPP4 (0.40) | DPP4DPP7 | |
| SCHEMBL7641265 | 0.75 | — | — | |
| SCHEMBL7400653 | 0.75 | DPP4 (0.31) | DPP4DPP7 | |
| SCHEMBL7289113 | 0.72 | CHRM2 (0.42) | — | |
| SCHEMBL19401307 | 0.72 | DPP4 (0.33) | DPP4DPP7 | |
| SCHEMBL910706 | 0.72 | EPHX2 (0.30) | — | |
| SCHEMBL22147939 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1590491-B1 | ADDUCTS BASED ON CYCLIC COMPOUNDS AND THE USE THEREOF AS TANNING AGENTS AND CURING AGENTS | BASF SE (DE) | 2011-06-01 | — | — | EP | disclosed |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2255780-A1 | PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| EP-1590492-B1 | TANNING AGENTS AND PRESERVATIVES | BASF SE (DE) | 2009-04-15 | — | — | EP | disclosed |
| US-7410504-B2 | Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-12 | — | — | US | disclosed |
| US-7282066-B2 | Processes for preparing and using tanning agents and preservatives | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-16 | — | — | US | disclosed |
| US-20070101509-A1 | Method for the production of leather and semifinished products, and formulations that are suitable therefor | BASF AKIENGESELLSCHAFT (DE) | 2007-05-10 | — | — | US | disclosed |
| EP-1670957-A1 | METHOD FOR THE PRODUCTION OF LEATHER AND SEMIFINISHED PRODUCTS, AND FORMULATIONS THAT ARE SUITABLE THEREFOR | BASF Aktiengesellschaft (DE) | 2006-06-21 | — | — | EP | disclosed |
| US-20060101583-A1 | Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-18 | — | — | US | disclosed |
| US-20060053564-A1 | Tanning agents and preservatives | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | US | disclosed |
| EP-1590491-A1 | ADDUCTS BASED ON CYCLIC COMPOUNDS AND THE USE THEREOF AS TANNING AGENTS AND CURING AGENTS | BASF Aktiengesellschaft (DE) | 2005-11-02 | — | — | EP | disclosed |
| EP-1590492-A1 | TANNING AGENTS AND PRESERVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-02 | — | — | EP | disclosed |
| WO-2005031007-A1 | METHOD FOR THE PRODUCTION OF LEATHER AND SEMIFINISHED PRODUCTS, AND FORMULATIONS THAT ARE SUITABLE THEREFOR | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-07 | — | — | WO | disclosed |
| WO-2004067781-A1 | ADDUCTS BASED ON CYCLIC COMPOUNDS AND THE USE THEREOF AS TANNING AGENTS AND CURING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004067782-A1 | TANNING AGENTS AND PRESERVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | CUTA, GLRA3, ARGLU1 | DPP4 1370/4885DPP7 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.